Katie Wright, Author at European Medical Journal - Page 15 of 45

NHS Opt-Out Testing Detects Hepatitis: EASL 2025

The study concludes that ED-based opt-out testing is both effective and acceptable in detecting hepatitis.

New Screening Model Enhances Hepatitis Care Access: EASL 2025

The study concludes that decentralised and person-centred hepatitis screening is effective and essential.

Triple-Modality Approach Offers Hope for Prostate Cancer

Early results support the theory that combining systemic and localised treatment in oligometastatic prostate cancer can improve tumour control.

How Inflammation Shapes Human Ageing and Health

Researchers developed a new evolutionary framework centred on immune robustness, the ability to fight infection while limiting damage.

Bacteria Found to Drive Prostate Cancer Progression

Commensal bacteria from the gut, urinary tract, and prostate tissue may play an unexpected role in the progression of prostate cancer.

Deep Learning Boosts CT Diagnosis of Heart Ischaemia

AI model improves heart disease risk prediction by analysing CT scans and identifying ischaemic heart volume automatically.

New Risk Model Predicts Hyperkalaemia in Chronic Kidney Disease and Type 2 Diabetes

New risk model predicts hyperkalaemia in CKD and diabetes, enabling tailored care and safer treatment decisions for patients.

Switch to Tirzepatide May Give Superior Glycaemic and Weight Benefits

Switching to tirzepatide yields greater HbA1c and weight reductions than escalating dulaglutide in Type 2 diabetes.

Rethinking High-Dose Aspirin in Kawasaki Disease Treatment

A recent randomised clinical trial sought to determine whether high-dose aspirin remains necessary during acute-stage KD treatment.

New Treatment Improves Platelet Levels in Liver Failure

Compared to controls, the rhTPO group experienced fewer bleeding events and a lower mortality rate.